Share chart Alseres Pharmaceuticals Inc
Extended chart
Simple chart
About Alseres Pharmaceuticals Inc
Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.| ISIN | US0211522026 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.alseres.com |
| Цена ао | 0.01 |
| Change price per day: | 0% (0.01) |
|---|---|
| Change price per week: | 0% (0.01) |
| Change price per month: | 0% (0.01) |
| Change price per 3 month: | 0% (0.01) |
| Change price per half year: | 0% (0.01) |
| Change price per year: | 0% (0.01) |
| Change price per 3 year: | -99.86% (7.25) |
| Change price per year to date: | 0% (0.01) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Peter G. Savas | Executive Chairman | 1948 (77 years) | |
| Mr. Sam Martin | Director of Finance & Corporate Compliance |
Address: United States, Auburndale, 275 Grove Street - open in Google maps, open in Yandex maps
Website: https://www.alseres.com
Website: https://www.alseres.com
